Retroviral proteins are synthesized as polyprotein precursors that undergo proteolytic cleavages to yield the mature viral proteins. The role of the human immunodeficiency virus (HIV) protease in the viral replication cycle was examined by use of a site-directed mutation in the protease gene. The HIV protease gene product was expressed in Escherichia coHl and observed to cleave HIV gag p55 to gag p24 and gag p17 in vitro. Substitution of aspartic acid residue 25 (Asp-25) of this protein with an asparagine residue did not affect the expression of the protein, but it eliminated detectable in vitro proteolytic activity against HIV gag p55. A mutant HIV provirus was constructed that contained the Asn-25 mutation within the protease gene. SW480 human colon carcinoma cells transfected with the Asn-25 mutant proviral DNA produced virions that contained gag p55 but not gag p24, whereas virions from cells transfected with the wild-type DNA contained both gag p55 and gag p24. The mutant virions were not able to infect MT-4 lymphoid cells. In contrast, these cells were highly sensitive to infection by the wild-type virions. These results demonstrate that the HIV protease is an essential viral enzyme and, consequently, an attractive target for anti-HIV drugs.
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The mature retroviral proteins encoded by the gag, pol, and env genes are derived from polyprotein precursors by posttranslational cleavage (1) . In human immunodeficiency virus (HIV), the gag, pol, and env polyproteins are processed to yield, respectively, the viral structural proteins p17, p24, and p15-reverse transcriptase and integrase-and the two envelope proteins gp41 and gpl20. Viral-encoded proteases have been biochemically characterized for several retroviruses, including the avian myeloblastosis virus (AMV; ref. 2) and the murine (MLV; ref. 3) , bovine (BLV; ref. 4) , and feline (FeLV; ref. 5) leukemia viruses. In vitro experiments with purified proteases from these viruses have confirmed that these enzymes are capable of cleaving the gag precursor polypeptides (3) (4) (5) (6) . Genes that would encode analogous proteases have been identified for all of the retroviruses whose genomes have been sequenced, including HIV-1 (7) (8) (9) . All of these retroviral proteases share limited amino acid homology with the active site residues of the family of aspartyl proteases represented by renin and pepsin (10) . Among these proteins, the sequence Asp-Thr-Gly is highly conserved, with the invariant aspartic acid being the active site aspartyl residue in the aspartyl proteases.
The necessity of these proteolytic processing steps in the life cycle of the retroviruses remains to be determined. Deletion of a region of the Moloney murine leukemia virus (MoMLV) genome that encodes the protease resulted in the production of noninfectious virions that contained unprocessed gag and pol precursor polypeptides (11, 12) . Although other processes could have been impaired by this large deletion in the gag-pol gene, this observation suggests that the MoMLV protease plays an essential role in maintaining the infectious nature of the virus. The gag-pol structure of HIV differs from that of MoMLV. Whereas the gag proteins of MoMLV are translated sequentially in the order p15, p12, p30, and plO (13) (14) (15) , the HIV gag products are translated sequentially as p17, p24, and p15 (7) (8) (9) , where HIV gag p24 is analogous to MoMLV gag p30. In addition, the HIV pol polypeptide is translated after a frameshift from the gag reading frame (16) and the MoMLV pol polypeptide is translated in the gag reading frame after suppression of a nonsense codon (3). These differences preclude a direct inference from the experiments with MoMLV on the role ofthe HIV protease.
In the case of HIV-1, the protease would be translated as the N-terminal region of the pol reading frame. Proteolytic activity has been observed to occur during expression in microbial cells of polypeptides that contain the 10-kDa polypeptide whose N-terminal sequence would initiate at pol resi- (19) . The Nco I/HindIll protease fragment was then subcloned into Nco I/HindIII-digested pPRT.
Abbreviations: HIV, human immunodeficiency virus; MoMLV, Moloney murine leukemia virus.
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During the construction of the pPRT plasmid, a plasmid was isolated that lacked the codon for the N-terminal methionine residue (pPRT-ATG). Details of these plasmid constructions will be published elsewhere. The HIV gag p55 substrate was expressed in yeast cells and isolated as a crude cytosolic preparation (to be described elsewhere). Rabbit anti-HIV protease antisera were raised against a peptide having the sequence NH2 -Glu-Glu-Met-Ser-Leu-Pro-Gly-Arg-Trp-ProLys-Met-COOH, which corresponds to residues 34-44 of the protease (unpublished data).
For expression of bacterially produced HIV protease, E. coli strain HB101 carrying the protease expression plasmids were grown to stationary phase in L broth (20) containing ampicillin (100 mg/liter) (Sigma). Cells were collected by centrifugation and resuspended in an equal volume of minimal medium (M9CA; ref. 20) supplemented with indolacrylic acid (20 tug/ml) (Sigma) and grown at 370C for 2.5 hr. Cells from a 5-ml culture were lysed in 0.25 ml of sample buffer A [50 mM Tris-HCI, pH 6.8/20% (vol/vol) glycerol/1% NaDodSO4/240 mM 2-mercaptoethanoll, and the proteins were separated by electrophoresis on 16% NaDodSO4/polyacrylamide gels and electroblotted onto nitrocellulose membranes. Membranes were incubated with rabbit anti-HIV protease antiserum (1:1000 dilution) in hybridization buffer (25 mM Tris-HCI, pH 7.5/150 mM NaCI/1% powdered milk/0.5% bovine serum albumin (Sigma)/1 mM CaCI2/20 ,uM EDTA) at 22°C for 1-3 hr and washed in 25 mM Tris-HCI, pH 7.5/150 mM NaCI/0.1% Tween 20 (Bio-Rad). Immunoreactive proteins were detected by autoradiography after incubation for 1-3 hr at 220C with 125I-labeled protein A (2 ,uCi; 1 Ci = 37 GBq; Amersham) in hybridization buffer.
To examine the activity of the bacterially expressed HIV protease, cells from a 5-ml culture of E. coli HB101 expressing the wild-type or mutant HIV protease were pelleted and resuspended in 0.25 ml of 50 mM Tris-HCI, pH 7.8/100 mM NaCl/5 mM EDTA/1 mM dithiothreitol/lysozyme (10 mg/ml)/l mM phenylmethylsulfonyl fluoride (Sigma)/aprotinin (10 ng/ml) (Sigma)/10 uM trans-epoxysuccinyl-lleucylamido(4-guanidino)butane (E-64, Sigma). Cells were kept on ice for 30 min and then disrupted by sonication for 4 min at 4°C. An aliquot (10 ,ul) of the soluble fraction was incubated with 4 ,ul of a crude preparation of yeast-produced HIV gag p55 (1 mg/ml) in a final volume of 20 ,ul and a final concentration of 50 mM 2-(N-morpholino)ethanesulfonic acid (pH 5.5). Reaction mixtures were incubated at 37°C for 1 hr and quenched by the addition of 10 ul of sample buffer A. Products were analyzed by electrophoresis on 16% NaDodSO4/polyacrylamide gels, electroblotted onto nitrocellulose membranes, and incubated first with murine monoclonal antibodies (DuPont) against HIV gag p24 and gag p17
(1:1000 dilution), and then with 125I-labeled goat anti-mouse antisera (2 ,uCi; Amersham) as described above.
Cells, Transfections, and Infections. SW480 human colon carcinoma cells (21) were grown in Dulbecco's modified Eagle's medium (Cellgro, Mediatech, Washington, DC) supplemented with 10% fetal calf serum. MT4 human lymphoid cells (22) were maintained in RPMI 1640 medium (GIBCO) supplemented with 10% heat-inactivated fetal calf serum.
SW480 cells were transfected with 10 ,ug of DNA per 106 cells in a 10-cm dish by the calcium phosphate method (23) . For infection of MT-4 cells, 1.0 x 106 cells were pelleted and resuspended in 1 ml of medium taken from the transfected SW480 cultures 48 hrposttransfection. Adsorption was allowed to proceed for 1 hr at 37°C with constant agitation, followed by the addition of 2 ml of fresh medium. Cells then were placed in individual wells of 48-well cell culture plates (Costar, Cambridge, MA) and incubated at 37°C.
Construction of HIy Protease Mutant Provirus. The HIV protease mutant provirus PM-3 was constructed by subcloning the 2.1-kilobase (kb) HindIII/Kpn I fragment of the HIV provirus pNL4-3 (24) containing the protease gene into bacteriophage M13 and performing oligonucleotide-directed mutagenesis as described for pPRT(Asn-25). The fragment was ligated with Nde I/Kpn I-digested pUC-18 together with the 3.4-kb Nde I/HindIII fragment of pNL4-3 containing the 5' long terminal repeat and gag sequences. The resulting plasmid first was digested with EcoRI, the end was made flush by Klenow polymerase I and then partially digested with BcE I, and the 6.6-kb fragment was isolated. This fragment was ligated with the Bcl I/EcoRI pol and Eco-RI/Nru I env fragments of pNL4-3 to give PM-3. The wild-type control WT-6 was made by replacing the 6.9-kb Sma I/Sal I fragment containing the mutation with the identical fragment from pNL4-3.
Analysis of Viral Proteins. For analysis of HIV proteins in transfected SW480 cells, one 10-cm dish of cells was starved for 4 hr, beginning 24 hr posttransfection, in medium lacking methionine. Cells were then labeled for 18 hr with 1 mCi of [35S~methionine (Amersham) in 10 ml of serum-free medium and lysed in 0.4 ml of RIPA buffer (1% Triton X-100/1% sodium deoxycholate/0.1% NaDodSO4/150 mM NaCl/10 mM Tris HCl, pH 7.2). The resultant extract was incubated with 50 ,l of fixed washed Staphylococcus aureus (Pansorbin, Calbiochem) for 10 min at 0°C, clarified by centrifugation, and incubated with S Al of anti-HIV antibody-positive antiserum from a seropositive healthy individual for 1 hr at 0°C. This antiserum is highly reactive with the HIV gag p24 protein and its precursor gag p55. Pansorbin (50 ,l) was then added and incubation was continued for 10 min at 0°C. The mixture was centrifuged for 15 min at 2000 x g and the resulting pellet was washed three times with 0.5 ml of RIPA buffer, once with 0.5 ml of 150 mM NaCl/10 mM Tris HCI, pH 7.5/1 mM EDTA, and resuspended in 55 ,ul of sample buffer B (62.5 mM Tris*HCl, pH 6.8/10% glycerol/2% NaDodSO4/5% 2-mercaptoethanol). Proteins were eluted from the bacteria by boiling and analyzed by electrophoresis on 10%6 NaDodSO4/polyacrylamide gels followed by autoradiography.
For analysis of viral proteins in the supernatants of transfected SW480 cells, supernatant from a 10-cm dish of [35S]methionine-labeled cells was clarified by centrifugation and concentrated 500-fold by using the Centriprep 10 System (Amicon). The concentrated supernatants were diluted to 0.4 ml with RIPA buffer, immunoprecipitated with human anti-HIV antibody-positive antiserum, and analyzed as described above.
For analysis of HIV proteins in infected MT-4 cells, half of the cells in a single well of a 48-well cell culture plate were lysed in 55 ,l of sample buffer B, and the proteins were separated by electrophoresis in 10% NaDodSO4/polyacrylamide gels and electroblotted onto Immobilon membranes (Millipore). Membranes were incubated with human anti-HIV antibody-positive antisera (1:500 dilution) in 20 mM Tris-HCI, pH 7.5/500 mM NaCl/0.1% Tween 20/5% powdered milk/5% immunoglobulin-free fetal calf serum (GIBCO) at 22°C for 1 hr and then washed with 20 mM Tris-HCI, pH 7.5/500 mM NaCI/0.1% Tween 20 either the wild-type or mutant protease were incubated with yeast-produced HIV gag p55 in vitro and the products were analyzed by NaDodSO4/PAGE followed by immunoblotting with a mixture of murine monoclonal antibodies against gag p24 and p17. As shown in Fig. 1B , the protease produced by pPRT cleaved p55 to give 24-and 17-kDa polypeptides that were immunologically indistinguishable from the viral p24 and p17 proteins. In contrast, no cleavage products were detected in reaction mixtures containing protease produced by pPRT(Asn-25) (Fig. 1B) Fig. 2 ). Detailed restriction mapping of the virus and sequencing of the region containing the mutation revealed no additional mutations (data not shown). As a control, a virus lacking the mutation, WT-6, was constructed by replacing the Sma I/Sal I fragment of PM-3 containing the mutation with the corresponding fragment from pNL4-3.
Transient Expression of Mutant Virus in SW480 Cells. Equivalent amounts of pNL4-3, WT-6, or PM-3 DNA were separately transfected into SW480 cells. SW480 cells are sensitive to DNA transfection and have been shown to transiently produce high levels of HIV (24) . Immunofluorescence staining with human anti-HIV antibody-positive antiserum was used to determine whether the transfected proviral DNAs were capable of directing the synthesis of viral proteins. As determined by immunoprecipitation and immunoblot analysis of HIV lysates, this antiserum contains antibodies to all of the major viral proteins and is highly reactive with the HIV gag p24 protein and its precursor p55. Viral antigens were detected in %5% of the cells transfected with pNL4-3, WT-6, or PM-3. No antigens were observed in mock-transfected SW480 cells (data not shown). Thus, HIV antigens were produced in a similar number of SW480 cells by the mutant and wild-type proviruses, indicating that the transfection efficiency of each of the plasmids was similar.
To examine production and processing of the gag p55 precursor polyprotein in SW480 cells transfected with the mutant and wild-type proviral DNAs, the cells were labeled with 35S]methionine and the intracellular viral proteins were immunoprecipitated with human anti-HIV antibody-positive antiserum and fractionated by NaDodSO4/PAGE. As shown in Fig. 3A, p55 was detected in cells transfected with both the wild-type and mutant DNAs. However, whereas cells transfected with pNL4-3 and WT-6 contained p24, cells transfected with PM-3 did not. A higher level of the p55 precursor was present in cells transfected with the mutant virus (Fig. 3A) . This observation is consistent with the absence of the p24 product in these cells and indicates that the mutant protease was completely blocked in its ability to process p55 in vivo.
The presence of viral proteins in the supernatants of the transfected SW480 cultures also was examined by radioactive labeling and immunoprecipitation with human anti-HIV antibody-positive antiserum. Viral proteins were detected in the supernatants from all of the cultures (Fig. 3B) 4 days postinfection. These cultures exhibited a total cytopathic effect by 6 days. Inmmunoblot analysis of the intracellular viral proteins produced in MT-4 cells infected with these wild-type viruses indicated that, as expected, p55 was processed to yield p24 (Fig. 4) . In contrast, no viral antigens Were detected by immunofluorescence or immunoblot analysis in MT-4 cells infected with the PM-3 mutant (Fig. 4) . These cultures remained healthy 
DISCUSSION
Substitution of Asp-25 with an asparagine residue eliminated the ability of the HIV protease expressed in E. coli to cleave HIV gag p55. This observation demonstrates that Asp-25 is essential for activity of the enzyme, and strengthens the proposed association of the retroviral proteases with the family of aspartyl proteases that includes renin and pepsin (10) . Analogy with pepsin and renin, in which the conserved aspartyl residue is at the active site, suggests that Asp-25 would participate in the catalytic mechanism of the enzyme. Therefore, its substitution might result in loss of enzymatic activity with no effect on conformation. Thus, this single nucleotide substitution afforded an ideal probe for the importance of the protease in the replication cycle of HIV. Incorporation of the protease Asn-25 mutation in the HIV provirus did not noticeably affect the expression of the gag polyprotein within transfected SW480 cells or the assembly and release of virions into the medium. Significantly, the virions produced by the Asn-25 mutant provirus contained gag p55 but were devoid of gag p24, reflecting a defect in in vivo proteolytic processing. Whereas both the mutant and wild-type proviruses directed the synthesis of virions, only the wild-type virions were infectious when assayed on the highly sensitive MT-4 lymphoid cells. Thus, inability of the mutant virus to infect MT-4 cells correlates with the loss of gag p55 cleavage. Studies of other retroviruses suggest that the viral protease might be responsible for cleavage of the pol gene product as well (11) . Insufficient levels of viral protein obtained from the transfected cell cultures prevented the analysis of the processing of the pol and env gene products during viral maturation. The current experiment could not distinguish which of the proteolytic events is critical.
The HIV genome is known to encode three enzymesreverse transcriptase, integrase, and protease. A previous study with a mutant that expressed a truncated pol gene product suggested that either reverse transcriptase or integrase or both were essential for viral infectivity (25) . Here a single mutation that eliminated the activity of the HIV protease blocked the infectivity of the virus. These experiments, therefore, predict that inactivation of the HIV protease by a specific chemical compound should render the virus noninfectious.
